Sunny Kumar
Corporate Officer/Principal at MaRS Discovery District
Profile
Sunny Kumar is currently working as an Investment Manager at MaRS Discovery District since 2007.
Prior to this, he worked as a Director at Receptor Therapeutics, Inc. Dr. Kumar completed his undergraduate and doctorate degrees from the University of Toronto.
Sunny Kumar active positions
Companies | Position | Start |
---|---|---|
MaRS Discovery District
MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/2007 |
Former positions of Sunny Kumar
Companies | Position | End |
---|---|---|
Receptor Therapeutics, Inc.
Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Director/Board Member | - |
Training of Sunny Kumar
University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
MaRS Discovery District
MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Commercial Services |
Receptor Therapeutics, Inc.
Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Sunny Kumar